Anticounterfeiting strategy launched in uk

Pharmaceutical Technology, 05/21/2012

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new anticounterfeiting strategy with the aim of curbing the occurrence of falsified medicines in the county’s supply chain. The strategy will focus on prevention, incident management, and investigation of all reports of falsified medicines in the UK.

Print Article Summary Cat 2 CME Report